SOURCES:
Jonathan Whiteson, MD, co-director, NYU Langone Health Post COVID Care Program.
American Academy of Physical Medicine and Rehabilitation: “Long COVID/PASC.”
Lancet: “Risk of Long COVID Associated With Delta Versus Omicron Variants of SARS-CoV-2.”
Nature Communications: “Post-Covid Medical Complaints Following Infection With SARS-CoV-2 Omicron vs Delta Variants.”
Karin Magnusson, PhD, researcher, Norwegian Institute of Public Health, Oslo, and Lund University, Sweden.
FDA: “COVID-19 Bivalent Vaccine Boosters.”
medRxiv: “Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study From the RECOVER Program.”
Antimicrobial Stewardship & Healthcare Epidemiology: “The Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccine in the Prevention of Post-COVID Conditions: A Systematic Literature Review and Meta-Analysis.”
Alexandre Marra, MD,…
